Board of Directors

Jack Davis - Interim Chief Executive Officer
Jack Davis was appointed as Chairman of Asterand in May 2008 and Interim Chief Executive Officer in July 2011. He was previously on the Board of Asterand Inc. prior to its merger with Pharmagene plc. He also serves on the Boards of Claros, Inc., Collages.net, Inc., Laboratory Partners, Inc., RedPath Integrated Pathology, Inc. and HistoRx, Inc. Mr. Davis co-founded Dianon Systems, a company that specializes in providing pathology services, holding the position of CEO, Chairman and Director. He has also served as CEO and Director of Calpyte Biomedical Corporation, Genica Pharmaceuticals and Infant Advantage, Inc. For over 15 years, Mr. Davis served in various executive positions with Abbott Laboratories, the last being Vice President and General Manager of Worldwide Diagnostic Products.


Executive Directors
Non-Executive Directors

Dr. Peter Coggins - Non-Executive Director (Senior Independent Director)
Peter Coggins was appointed as a Non-Executive Director of Asterand plc in April 2008. Dr. Coggins has over thirty-five years experience in the biotechnology and life science industry. Previously he was President of PerkinElmer Inc. Life and Analytical Sciences, and as such had full P&L responsibility for a business with sales of $1.2 billion and staff of 4,200. In this capacity he also served as a Corporate Officer and a member of the Executive Committee. Prior to PerkinElmer, Dr. Coggins served as Executive VP Global Sales, at Amersham Biosciences. Dr. Coggins is a past Chairman of ALSSA (Analytical & Life Science Sciences Association), a former advisory committee member to the US Secretary of Health and Human Services, and is a former Director on the Boards of Biohit Oy (Helsinki) and deltaDOT Ltd (London). Dr. Coggins holds a first degree and a Ph.D. in Zoology from Chelsea College, University of London.

Jill L. Force - Non-Executive Director
Jill Force was appointed as a Non-Executive Director of Asterand plc in June 2008. Ms. Force is currently a Partner with The Allegro Group, Inc. (Louisville, KY) which provides interim management and business advisory services to public and private healthcare companies as well as equity and venture capital firms. Prior to this position, she served as Executive Vice President, General Counsel and Chief Administrative Officer for Life-Care, a privately held company that operates 20 long term acute care hospitals. Ms. Force spent 10 years as SVP, General Counsel and Corporate Secretary for Vencor, Inc. (now Kindred Healthcare, Inc.) where she was part of a team that grew the company from one hospital to a Fortune 500 operator of hospitals, nursing facilities and contract medical services. Ms. Force is a certified public accountant and an attorney with a degree in Political Science from Miami University, a Master of Science in Accounting from Georgetown University and a Juris Doctorate from University of the Louisville School of Law.

Robert Salisbury - Non-Executive Director
Robert Salisbury was appointed as a Non-Executive Director of Asterand plc in June 2008. Mr. Salisbury has more than 20 years of experience in the pharmaceutical industry. Previously, he was Executive Vice President & Chief Financial Officer of Pharmacia & Upjohn Inc (Windsor UK) and as such had full responsibility for the finance, corporate strategy, human resources, investor relations & corporate communication functions within the company. In this capacity, he was integral to implementation of the post-merger global integration of the two companies across its units and subsidiaries within 48 countries. Mr. Salisbury has extensive investor contacts through his involvement in Pharmacia's $4 billion secondary stock offering and other investor relations activities. Mr. Salisbury has a degree in Finance and an M.B.A. from Florida State University. Mr. Salisbury is currently a Director and Chair of the Audit Committee at Enzon Pharmaceuticals Inc (Bridgewater, NJ).